Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136200616> ?p ?o ?g. }
- W3136200616 abstract "Abstract Approximately 10% of infants will experience COVID-19 illness requiring advanced care (1). A potential mechanism to protect this population could be provided by passive immunity through the milk of a previously infected mother. We and others have reported on the presence of SARS-CoV-2-specific antibodies in human milk (2-5). We now report the prevalence of SARS-CoV-2 IgA in the milk of 75 COVID-19-recovered participants, and find that 88% of samples are positive for Spike-specific IgA. In a subset of these samples, 95% exhibited robust IgA activity as determined by endpoint binding titer, with 50% considered high-titer. These IgA positive specimens were also positive for Spike-specific antibodies bearing the secretory component. Levels of IgA antibodies and antibodies bearing secretory component were shown to be strongly positively correlated. The secretory IgA response was dominant among the milk samples tested compared to the IgG response, which was present in 75% of samples and found to be of high-titer in only 13% of cases. Our IgA durability analysis using 28 paired samples, obtained 4-6 weeks and 4-10 months after infection, found that all samples exhibited persistently significant Spike-specific IgA, with 43% of donors exhibiting increasing IgA titers over time. Finally, COVID-19 and pre-pandemic control milk samples were tested for the presence of neutralizing antibodies; 6 of 8 COVID-19 samples exhibited neutralization of Spike-pseudotyped VSV (IC 50 range, 2.39 – 89.4ug/mL) compared to 1 of 8 controls. IgA binding and neutralization capacities were found to be strongly positively correlated. These data are highly relevant to public health, not only in terms of the protective capacity of these antibodies for breastfed infants, but also for the potential use of such antibodies as a COVID-19 therapeutic, given that secretory IgA is highly stable not only in milk and the infant mouth and gut, but in all mucosa including the gastrointestinal tract, upper airway, and lungs (6)." @default.
- W3136200616 created "2021-03-29" @default.
- W3136200616 creator A5003224926 @default.
- W3136200616 creator A5031218633 @default.
- W3136200616 creator A5041332295 @default.
- W3136200616 creator A5045400450 @default.
- W3136200616 creator A5058015853 @default.
- W3136200616 creator A5070606892 @default.
- W3136200616 creator A5071125492 @default.
- W3136200616 creator A5079678684 @default.
- W3136200616 creator A5084026286 @default.
- W3136200616 date "2021-03-20" @default.
- W3136200616 modified "2023-09-26" @default.
- W3136200616 title "The Spike-specific IgA in milk commonly-elicited after SARS-Cov-2 infection is concurrent with a robust secretory antibody response, exhibits neutralization potency strongly correlated with IgA binding, and is highly durable over time" @default.
- W3136200616 cites W1970244022 @default.
- W3136200616 cites W1983068958 @default.
- W3136200616 cites W2007454130 @default.
- W3136200616 cites W2804879551 @default.
- W3136200616 cites W3010819577 @default.
- W3136200616 cites W3012284084 @default.
- W3136200616 cites W3014206579 @default.
- W3136200616 cites W3016269138 @default.
- W3136200616 cites W3024580769 @default.
- W3136200616 cites W3081574033 @default.
- W3136200616 cites W3088515688 @default.
- W3136200616 cites W3110067964 @default.
- W3136200616 cites W3133448246 @default.
- W3136200616 doi "https://doi.org/10.1101/2021.03.16.21253731" @default.
- W3136200616 hasPublicationYear "2021" @default.
- W3136200616 type Work @default.
- W3136200616 sameAs 3136200616 @default.
- W3136200616 citedByCount "8" @default.
- W3136200616 countsByYear W31362006162021 @default.
- W3136200616 countsByYear W31362006162022 @default.
- W3136200616 crossrefType "posted-content" @default.
- W3136200616 hasAuthorship W3136200616A5003224926 @default.
- W3136200616 hasAuthorship W3136200616A5031218633 @default.
- W3136200616 hasAuthorship W3136200616A5041332295 @default.
- W3136200616 hasAuthorship W3136200616A5045400450 @default.
- W3136200616 hasAuthorship W3136200616A5058015853 @default.
- W3136200616 hasAuthorship W3136200616A5070606892 @default.
- W3136200616 hasAuthorship W3136200616A5071125492 @default.
- W3136200616 hasAuthorship W3136200616A5079678684 @default.
- W3136200616 hasAuthorship W3136200616A5084026286 @default.
- W3136200616 hasBestOaLocation W31362006161 @default.
- W3136200616 hasConcept C126322002 @default.
- W3136200616 hasConcept C14086860 @default.
- W3136200616 hasConcept C159047783 @default.
- W3136200616 hasConcept C159654299 @default.
- W3136200616 hasConcept C202751555 @default.
- W3136200616 hasConcept C203014093 @default.
- W3136200616 hasConcept C22889606 @default.
- W3136200616 hasConcept C2779102806 @default.
- W3136200616 hasConcept C2779134260 @default.
- W3136200616 hasConcept C2779341262 @default.
- W3136200616 hasConcept C2780898057 @default.
- W3136200616 hasConcept C2908647359 @default.
- W3136200616 hasConcept C2909509916 @default.
- W3136200616 hasConcept C2909735910 @default.
- W3136200616 hasConcept C3008058167 @default.
- W3136200616 hasConcept C32611913 @default.
- W3136200616 hasConcept C524204448 @default.
- W3136200616 hasConcept C55493867 @default.
- W3136200616 hasConcept C57992300 @default.
- W3136200616 hasConcept C71924100 @default.
- W3136200616 hasConcept C86803240 @default.
- W3136200616 hasConcept C8891405 @default.
- W3136200616 hasConcept C99454951 @default.
- W3136200616 hasConceptScore W3136200616C126322002 @default.
- W3136200616 hasConceptScore W3136200616C14086860 @default.
- W3136200616 hasConceptScore W3136200616C159047783 @default.
- W3136200616 hasConceptScore W3136200616C159654299 @default.
- W3136200616 hasConceptScore W3136200616C202751555 @default.
- W3136200616 hasConceptScore W3136200616C203014093 @default.
- W3136200616 hasConceptScore W3136200616C22889606 @default.
- W3136200616 hasConceptScore W3136200616C2779102806 @default.
- W3136200616 hasConceptScore W3136200616C2779134260 @default.
- W3136200616 hasConceptScore W3136200616C2779341262 @default.
- W3136200616 hasConceptScore W3136200616C2780898057 @default.
- W3136200616 hasConceptScore W3136200616C2908647359 @default.
- W3136200616 hasConceptScore W3136200616C2909509916 @default.
- W3136200616 hasConceptScore W3136200616C2909735910 @default.
- W3136200616 hasConceptScore W3136200616C3008058167 @default.
- W3136200616 hasConceptScore W3136200616C32611913 @default.
- W3136200616 hasConceptScore W3136200616C524204448 @default.
- W3136200616 hasConceptScore W3136200616C55493867 @default.
- W3136200616 hasConceptScore W3136200616C57992300 @default.
- W3136200616 hasConceptScore W3136200616C71924100 @default.
- W3136200616 hasConceptScore W3136200616C86803240 @default.
- W3136200616 hasConceptScore W3136200616C8891405 @default.
- W3136200616 hasConceptScore W3136200616C99454951 @default.
- W3136200616 hasLocation W31362006161 @default.
- W3136200616 hasOpenAccess W3136200616 @default.
- W3136200616 hasPrimaryLocation W31362006161 @default.
- W3136200616 hasRelatedWork W1972745941 @default.
- W3136200616 hasRelatedWork W1984647379 @default.
- W3136200616 hasRelatedWork W2063036651 @default.
- W3136200616 hasRelatedWork W2380992408 @default.
- W3136200616 hasRelatedWork W2399135511 @default.
- W3136200616 hasRelatedWork W3134744114 @default.